P&G’s CFO sells 31.9% of directly held shares from an option exercise (NYSE: PG)

What happened

Procter & Gamble Co (NYSE: PG) Chief Financial Officer Andre Schulten exercised stock options and sold 30,677 shares on Nov. 5 at $169.00 each. The trade totaled about $5.18 million.

The filing says the shares sold came from stock options exercised the same day. Those options carried a $78.52 exercise price, which put the sale price $90.48 per share above it. Their exercise window ran from Feb. 26, 2021 to Feb. 28, 2028.

The Form 4 lists zero of those options remaining after the exercise. Both the exercise and the sale carry Nov. 5 dates. Schulten also holds 7,604.419 shares through a retirement plan trustee, reported apart from the direct holding. The form is dated Nov. 9.

Key numbers

Metric	Latest	Change	Source
Shares sold	30,677 shares		SEC Form 4
Sale price per share	$169.00		SEC Form 4
Total value of sale	$5.18 million		SEC Form 4
Option exercise price	$78.52		SEC Form 4
Shares held directly after sale	65,618 shares		SEC Form 4
Sale as share of direct holding before the trade	31.9%		Calculated from SEC Form 4

Read more: Procter & Gamble (PG) company research

Why it matters

Schulten ended with 65,618 shares held directly, the same count as before the options were exercised, because the sale removed exactly the shares the exercise added. The trade turned options into cash, locking in the gap between exercise and sale price, without reducing shares Schulten already owned.

By OptimistFi's calculation, the sale equaled 31.9% of the 96,295 shares held directly right after the exercise, excluding the retirement plan shares. Because the filing ties the shares to that same-day option exercise, the sale is hard to read as a verdict on P&G.

The Form 4 reports the option exercise and the sale as two separate entries on Nov. 5. The retirement plan shares sit outside that direct count.

OptimistFi has argued that P&G turns category-leading brands and global scale into steady organic growth and durable shareholder returns. A sale of that size by the CFO is a small mark against that view, though the option exercise and the unchanged share count blunt it.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

P&G's next quarterly report is the next scheduled check on the organic growth and cash generation the case rests on. Steady results would strengthen the case, while a slowdown would weaken it. The sale itself changes little either way.

More from OptimistFi

• PG stock: research and coverage of Procter & Gamble
• Stock research on every company OptimistFi covers

From OptimistFi Perps